ArticleCureus2026
Understanding CT Resolution Timeline in Acute Pyelonephritis: A Framework for Clinical Practice.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Acute pyelonephritis is diagnosed based on clinical and laboratory signs. Computed tomography (CT) is typically reserved for detecting complications or alternative diagnoses. Current guidelines do not recommend routine follow-up imaging when abnormalities are found. The expected time to resolution (TTR) of CT abnormalities has not been clearly identified, which serves as the goal of our study. Methodology This retrospective study was conducted at an academic hospital in Harris County, Texas. Adult patients with a diagnosis of acute pyelonephritis who underwent at least two CT scans were included. Three board-certified radiologists independently reviewed CT studies performed within one year of the index scan and assessed for striated nephrogram, parenchymal edema, patchy hypodensities, perinephric fat stranding, and urothelial thickening. Time to first documented radiologic resolution (TTR) was defined as the interval between the first positive CT sign and the first subsequent CT in which the sign was absent. TTR was calculated for individual signs and globally, provided clinical criteria for pyelonephritis were met. Sensitivity, specificity, and inter-rater agreement were also evaluated. Results A total of 288 CT scans from 93 patients were reviewed, of which 252 (88%) were of sufficient quality for analysis. The mean global TTR was 149 ± 100 days, with wide variation across individual signs. Moreover, imaging abnormalities persisted for 105 days despite clinical resolution. Conclusions CT signs consistent with pyelonephritis may persist for several months after clinical recovery. Clinicians should interpret persistent imaging abnormalities appropriately to avoid unnecessary diagnostic or therapeutic interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.